Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area tyrosine kinase fak'

Search results for: 'research area tyrosine kinase fak'

Items 101-110 of 245

Page
per page
  1. Vemurafenib (PLX4032, RG7204)
    A3004 Vemurafenib (PLX4032, RG7204)
     9 Citation
    Target: Raf
    Summary: BRAF kinase inhibitor
      ≥24.5 mg/mL
  2. Trametinib DMSO solvate
    A3887 Trametinib DMSO solvate
     1 Citation
    Target: MEK
    Summary: Allosteric MEK1/MEK2 kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥11.2 mg/mL
  3. SB 239063
    A3792 SB 239063
     1 Citation
    Target: p38
    Summary: P38 MAP kinase inhibitor
      insoluble in H2O; ≥18.4 mg/mL
  4. LY2584702
    B5815 LY2584702
    Target: p70 rsk
    Summary: p70 S6 kinase inhibitor
      ≥22.25 mg/mL
  5. CGI-1746
    A3302 CGI-1746
     1 Citation
    Target: BTK
    Summary: Btk inhibitor
      ≥29 mg/mL
  6. BAY 61-3606
    A3227 BAY 61-3606
    Target: Syk
    Summary: Syk Inhibitor
      insoluble in H2O; insoluble in EtOH; ≥7.94 mg/mL
  7. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     2 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL
  8. Tofacitinib (CP-690550,Tasocitinib)
    A4138 Tofacitinib (CP-690550,Tasocitinib)
     1 Citation
    Target: JAK
    Summary: Janus kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥15.6 mg/mL
  9. NH125
    A8814 NH125
     1 Citation
    Target: eEF-2
    Summary: Selective eEF-2 kinase inhibitor
      ≥25.9 mg/mL
  10. LKB1 (AAK1 dual inhibitor)
    A3556 LKB1 (AAK1 dual inhibitor)
    Target: Pim
    Summary: Pim-1 kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥34.8 mg/mL

Items 101-110 of 245

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 242item
  2. Peptides 1 item
  3. Peptides & Proteins 1 item
Reversibility
  1. Reversible 21item
  2. Irreversible 5item
Target
  1. Cyclin-Dependent Kinases 21item
  2. Akt 1 item
  3. PI3K 12item
  4. Raf 7item
  5. Aurora Kinases 13item
  6. CSF-1R 2item
  7. mTOR 6item
  8. FLT3 8item
  9. GSK-3 7item
  10. PLK 4item
  11. Chk 5item
  12. Eph Receptors 3item
  13. VEGFR 19item
  14. PDGFR 14item
  15. c-Kit 6item
  16. RET 3item
  17. IRAK 2item
  18. Bromodomain-containing proteins(BRDs) 1 item
  19. p38 6item
  20. PKB 1 item
  21. JNK 2item
  22. SGK 2item
  23. Bcr-Abl 10item
  24. MEK 4item
  25. FGFR 6item
  26. Pim 4item
  27. Ribosomal s6 kinases (RSK) 1 item
  28. MET 5item
  29. Src 8item
  30. Trk Receptors 3item
  31. STAT 1 item
  32. EGFR 10item
  33. ROCK 6item
  34. BTK 1 item
  35. PAK 3item
  36. FAK 5item
  37. BMP and Other Activin Receptors 2item
  38. JAK 9item
  39. Syk 5item
  40. DNA-PK 3item
  41. AMPK 2item
  42. PDHK 1 item
  43. ErbB 2item
  44. S6 kinases 1 item
  45. Adenosine Kinases 2item
  46. ERK 2item
  47. c-MET 5item
  48. PKC 5item
  49. Ubiquitin-specific proteases 1 item
  50. Ca2 /calmodulin-dependent protein kinases (CaMKs) 6item
  51. Lyn 1 item
  52. HER2 2item
  53. Pyk2 3item
  54. LRRK2 3item
  55. Insulin and Insulin-like Receptors 2item
  56. ALK 3item
  57. ROS1 1 item
  58. Sphingosine kinases (SphKs) 1 item
  59. PKG 1 item
  60. PKA 1 item
  61. Myosin light chain kinases (MLCKs) 2item
  62. CaM-KK 1 item
  63. MELK 1 item
  64. Insulin-like growth factors (IGFs) 1 item
  65. Clk 1 item
  66. NUAK1 1 item
  67. NUAK2 1 item
  68. MK2 2item
  69. Fatty-acid-binding proteins (FABPs) 1 item
  70. Tie-2 2item
  71. RSK 1 item
  72. ATM/ATR 3item
  73. CK1 1 item
  74. Farnesyl Diphosphate Synthases 1 item
  75. CK2 3item
  76. HIPK2 1 item
  77. HIPK3 1 item
  78. P2X Receptors 1 item
  79. c-Fyn 1 item
  80. TAK1 1 item
  81. P110 1 item
  82. Hck 1 item
  83. Insulin Receptors 1 item
  84. IRG-1R 1 item
  85. Cdc2-like kinase (Clk) 1 item
  86. eEF-2 1 item
  87. Cdc7 1 item
  88. ZAP-70 1 item
  89. c-RET 1 item
  90. p70 rsk 1 item
  91. TAM kinase 1 item
  92. AXL 1 item
  93. c-Fms tyrosine kinase 1 item
  94. STK 1 item
  95. MSK 1 item
  96. Lyn kinase 1 item
  97. ITK 1 item
  98. NUAK 1 item
  99. DCLK2 1 item
  100. Lck 1 item
  101. PKD 1 item
  102. tropomyosin receptor kinase 1 item
  103. SK 1 item
  104. ATM 1 item
  105. PIKfyve 1 item
  106. Insulin Receptor 1 item
Reported Experiments
  1. Animal Experiments 211item
  2. Cell Experiments 129item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 16item
  3. Adrenocortical Carcinoma 2item
  4. Advanced Renal Cell Carcinoma 1 item
  5. Bladder Cancer 4item
  6. Bladder Carcinoma 1 item
  7. B-lymphoid Malignancies 1 item
  8. Breast Cancer 43item
  9. Cancer 155item
  10. Cervical Cancer 4item
  11. Cholangiocarcinoma 2item
  12. Chronic Lymphocytic Leukemia 2item
  13. Clear Cell Renal Cell Carcinoma 1 item
  14. Colon Cancer 20item
  15. Colon Carcinoma 2item
  16. Colorectal Cancer 19item
  17. Diabetes 1 item
  18. Glioblastoma 17item
  19. Glioma 7item
  20. Hepatocellular Carcinoma 4item
  21. HIV Infections 1 item
  22. Immunological Diseases 1 item
  23. Inflammatory Bowel Disease 1 item
  24. Inflammatory Diseases 4item
  25. Leukemia 7item
  26. Liver Cancer 3item
  27. Lung Cancer 15item
  28. Lung Carcinoma 3item
  29. Lymphoma 9item
  30. Mantle Cell Lymphoma 1 item
  31. Melanoma 11item
  32. Multiple Myeloma 6item
  33. Myelofibrosis 1 item
  34. Myeloma 1 item
  35. Neuroblastoma 2item
  36. Non-small Cell Lung Cancer 5item
  37. Non-small Cell Lung Carcinoma 1 item
  38. Ovarian Cancer 15item
  39. Pancreatic Cancer 22item
  40. Prostate Cancer 17item
  41. Psoriasis 1 item
  42. Pulmonary Arterial Hypertension 1 item
  43. Renal Cancer 3item
  44. Renal Cell Carcinoma 5item
  45. Rheumatoid Arthritis 5item
  46. Thyroid Cancer 5item
  47. Type 2 Diabetes 3item